SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001546927-15-000263
Filing Date
2015-10-20
Accepted
2015-10-20 14:18:07
Documents
1
Period of Report
2015-10-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT camberprotalixform4filed.html 4  
1 OWNERSHIP DOCUMENT camberprotalixform4filed.xml 4 7121
  Complete submission text file 0001546927-15-000263.txt   8969
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Reporting) CIK: 0001444043 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 151166121